Open Access. Powered by Scholars. Published by Universities.®
Biological Phenomena, Cell Phenomena, and Immunity Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Life Sciences (4)
- Medical Cell Biology (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (3)
- Biochemistry, Biophysics, and Structural Biology (3)
- Anatomy (2)
-
- Cells (2)
- Investigative Techniques (2)
- Medical Specialties (2)
- Allergy and Immunology (1)
- Bacteriology (1)
- Biochemistry (1)
- Biological Factors (1)
- Cancer Biology (1)
- Cardiovascular System (1)
- Cell and Developmental Biology (1)
- Chemicals and Drugs (1)
- Circulatory and Respiratory Physiology (1)
- Diseases (1)
- Equipment and Supplies (1)
- Genetic Phenomena (1)
- Immunology and Infectious Disease (1)
- Immunopathology (1)
- Medical Immunology (1)
- Medical Microbiology (1)
- Medical Molecular Biology (1)
- Medical Neurobiology (1)
- Medical Pathology (1)
- Institution
- Keyword
Articles 1 - 6 of 6
Full-Text Articles in Biological Phenomena, Cell Phenomena, and Immunity
Novel Biomarker Discovery In Multiple Sclerosis, Manisha Gangasani
Novel Biomarker Discovery In Multiple Sclerosis, Manisha Gangasani
Honors Theses
Multiple Sclerosis (MS) is a chronic neuroinflammatory disorder affecting the brain, spinal cord, and optic nerve. Patients experience cognitive, motor, autonomic, and emotional symptoms that often overlap with other neurological conditions, making early diagnosis challenging. Current diagnostic criteria require evidence of lesions with dissemination in time and space. Racial disparities in MS outcomes are well documented, with Black individuals often exhibiting greater disease severity, higher relapse rates, and increased disability compared to White individuals. These differences likely reflect a combination of genetic, biological, environmental, and healthcare access factors, underscoring the need to improve early diagnosis and reduce inequities in care. …
Developing A Protocol For Non-Cellular Transplantation Of Donor Mitochondria Into Recipient Cells, Andrew Parton
Developing A Protocol For Non-Cellular Transplantation Of Donor Mitochondria Into Recipient Cells, Andrew Parton
Honors Theses
Tumor innervation has emerged as a critical feature of cancer progression, with increased nerve density correlating with enhanced aggressiveness, metastatic dissemination, and poor clinical outcome. However, the functional contribution of neurons to tumor biology remains incompletely defined. We recently identified the intercellular transfer of mitochondria from neurons to cancer cells as a mechanism that promotes tumor progression. We therefore hypothesized that disruption of this transfer could attenuate tumor aggressivity. To directly investigate this process, we developed an approach to isolate mitochondria from donor cells and transplant them into recipient cancer cells independently of canonical cell-cell interactions. Transferred mitochondria were tracked …
Pseudomonas Aeruginosa Exoenzyme Y Enzymatic Activity Inhibits Exoenzyme S-Induced Caspase Activation But Not Cytotoxicity In Pulmonary Microvascular Endothelial Cells, Connor Holm
Honors Theses
Pseudomonas aeruginosa (P. aeruginosa) is the most common cause of ventilator-associated pneumonia in intensive care unit patients. P. aeruginosa utilizes a type III secretion system that injects exoenzymes U, S, T, and/or Y into the host cell cytosol. A majority of clinically isolated P. aeruginosa strains express ExoY often in combination with ExoU and ExoT, or ExoS and ExoT. Host signaling mechanisms in response to intoxication with individual exoenzymes have been extensively studied, yet little is known about host cell response to co-intoxication. In this study, pulmonary microvascular endothelial cells (PMVECs) were infected with P. aeruginosa strains expressing different combinations …
Finding The Optimal Ionic Liquid To Target White Blood Cell Subpopulations Using Nanoparticles, Meghan Gorniak
Finding The Optimal Ionic Liquid To Target White Blood Cell Subpopulations Using Nanoparticles, Meghan Gorniak
Honors Theses
Disorders and diseases of the immune system have become more prevalent in recent decades and can have life-threatening effects on those afflicted. Granulocyte disorders disproportionately affect infants and children, while chronic lymphocytic leukemia is the most common type of leukemia in adults. Unfortunately, current treatments have many drawbacks such as everyday injection, short-lived efficacy, and unknown levels of safety and effectiveness. It is imperative to find more effective treatment options that could allow for easier drug delivery to specific populations of white blood cells (WBCs). Nanoscale medicine shows promising application, but complications remain in reaching the desired target site and …
Development Of An Immunoblot To Detect Human Antibodies Against Sars-Cov-2 Virus Proteins, Shivum Desai
Development Of An Immunoblot To Detect Human Antibodies Against Sars-Cov-2 Virus Proteins, Shivum Desai
Honors Theses
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a virus that infects cells in the lungs, nasal passages, and intestines via the ACE2 receptors of the host, and leads to the coronavirus disease (COVID-19). Since the occurrence of the pandemic in December 2019, there have been 114 million cases worldwide in which 2.5 million lives have unfortunately been taken away.
Being diagnosed with a past infection stems questions among those that have tested positive through antibody testing. The problem here is that patients were notified that they have antibodies resulting from a SARS-CoV-2 infection, but in fact they may not …
Retinal Ganglion Cell Neuroprotection Induced By Neuropharmacological Agents In An In-Vivo Model Of Glaucoma, Quinn Ameel
Retinal Ganglion Cell Neuroprotection Induced By Neuropharmacological Agents In An In-Vivo Model Of Glaucoma, Quinn Ameel
Honors Theses
Recent discoveries from this lab have demonstrated that activation of alpha7 nicotinic acetylcholine receptors (α7 nAChRs) on retinal ganglion cells (RGCs) in the retina is linked to neuroprotection of RGCs that are typically lost in glaucoma-like conditions. Various chemical agents have been produced to increase overall neurotransmission of ACh from cholinergic neurons. DMP-543 is an agent that increases calcium release from cholinergic synaptic terminals. Donepezil is an acetylcholinesterase inhibitor that inhibits the breakdown of ACh in the synaptic cleft, prolonging ACh’s effect. In this study, the neuroprotective activity of these two agents was analyzed at the synapse between starburst amacrine …